MAPT and amyloidosis: Together, our results should motivate further research, assessing the exact mechanisms by which αSyn may accelerate the Aβ-tau axis, which could help us understand how to prevent the transition from amyloidosis to tauopathy in AD and potentially establish αSyn co-pathology as a treatment target in AD.